Search

everythinglearnresearchcommunity

for

Search:↓

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Clascoterone may be an effective topical treatment for hair loss.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Zinc, copper, and iron are important for skin health and may help diagnose skin diseases.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Acarbose may improve PCOS symptoms and fertility, but more research is needed.

The study's findings are unreliable due to retraction.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Phenol is effective for skin treatments but poses serious health risks and must be used cautiously by trained doctors.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.